Jonathan M Glenn, Chief Executive Officer at Consort Medical, holds 40.60M shares in Tissue Regenix (Ticker: GB:TRX), holds 395.42K shares in Consort Medical (Ticker: GB:CSRT). Most recently, Jonathan M Glenn Bought ― shares of Tissue Regenix on Jun 05, 2020 for an estimated value of 100.00K.